Fig. 3From: Transcutaneous supraorbital neurostimulation in “de novo” patients with migraine without aura: the first Italian experienceSignificant reduction in a mean headache severity during migraine attacks (p = 0.002); b HIT-6 questionnaire rating (p < 0.001) and c monthly intake of total rescue medication intake (p < 0.001), NSAID (including acetaminophen) (p = 0.02), and triptans intake (p = 0.04)Back to article page